Your Sunday article in the Star Ledger titled 'Today, the specter is autism'

[Guest guest]

Kathleen O'Brien,

I read your article with interest and

found that it was generally accurate

in many areas.

However, your parenthetical:

>(Use of thimerasol in routine vaccines

>was stopped in 2001.)

is a categorically false statement.

This is the case because the use of

Thimerosal in routine vaccines has

continued until the present.

The current list of FDA-licensed vaccines

is contained in the attached " doc " file.

If you do not accept e-mail attachments,

a rough text version of that file is

as follows:

March 2008 FDA-licensed Thimerosal-containing

Vaccines

[Taken From: FDA's " Table 3: Thimerosal and

Expanded List of Vaccines - (updated 3/14/2008)

Thimerosal Content in Currently Manufactured

U.S. Licensed Vaccines " & recent approvals]

No.[8] Vaccine Trade Name Manufacturer Thimerosal

Concentra-

tion[1]

*1 DTaP Tripedia[2] Sanofi Pasteur <= 0.00012%

Inc (SP-Inc)

*2 DTaPH TriHIBit SP-Inc/SA <= 0.00012%

(Tripedia+ActHIB[2])

*3 DT None SP-Inc < 0.00012%

(single dose)

*4/1 DT None SP-Ltd [3] 0.01%

(available but NOT marketed)

*5/2 Td None Mass Public 0.0033%

Health

*6 Td Decavac SP-Inc <= 0.00012%

7/3 TT None SP-Inc 0.01%

*8 HepA/ Twinrix Glaxo- < 0.0002%

HepB Kline Biologicals

(GSK-

#9/4 Influ- Afluria CSL Limited 0.01%

enza (multidose)

*10/5 Influ- Fluzone[6] SP-Inc 0.01%

enza

*11/6 Influ- Fluvirin Novartis 0.01%

enza Vaccines &

Diagnostics

Ltd (NV & D-Ltd)

*12 Influ- Fluvirin NV & D-Ltd < 0.0004%

enza (Preservative

Free)

#13 Influ- Fluarix GSK-B < 0.0004%

enza

#14/7 Influ- FluLaval ID Biomedical 0.01%

enza Corporation

of Quebec

15/8 Japanese JE-VAX Research Foun- 0.007%

Encepha- dation for

litis[7] Microbial Dis-

eases of Osaka

University

*16/9 Menin- Menomune A, SP-Inc 0.01%

gococcal C, AC and (multidose)

A/C/Y/W-135

17/10 Avian Influenza SP-Inc 0.0098%

Influ- Virus Vaccine, (multidose

enza[9] H5N1 with dosing

@ 0 & 2 mn)

Table Footnotes

1. Thimerosal is approximately 50% mercury (Hg)

by weight. A 0.01% solution (1 part per 10,000)

of thimerosal contains 50 µg of Hg per 1 mL

dose or 25 µg of Hg per 0.5 mL dose. Vaccines

with a nominal " preservative " level of

mercury have levels of Thimerosal between 0.003%

and 0.01%.

2. Sanofi Pasteur's Tripedia may be used to

reconstitute ActHib to form TriHIBit. TriHIBit

is indicated for use in children 15 to 18

months of age.

3. This vaccine is not marketed in the US but

it is available.

4. ...

5. ...

6. Children under 3 years of age receive a half-

dose of vaccine, i.e., 0.25 mL (12.5 µg Hg/

dose.)

7. JE-VAX is distributed by Aventis Pasteur.

Children 1 to 3 years of age receive a half-

dose of vaccine, i.e., 0.5 mL (17.5 µg Hg/

dose).

8. When there are two numbers separated by a

slash, " / " , the second numbers are the count

for the current Thimerosal-preserved vaccine

formulations that have FDA approval.

9. Approved April, 17 but not in " Table 3 "

because it is currently only licensed for

use in a pandemic outbreak; approvals for

children are pending or deferred.)

Of these " 17 " Thimerosal-containing

vaccines, " 11 " are vaccines approved

for use in routine vaccination programs

for children (those marked with an asterisk

[*]) though the Td and DT vaccines are being

phased out and replaced by two no-Thimerosal

Tdap vaccines, and " 3 " , marked with a pound

sign [#], are ONLY approved for routine

administration to adults, including pregnant

women, during the " flu " season.

Except for the Thimerosal-containing DTaP

and DTaPH vaccines, the other listed vac-

cines that are approved for routine use

in children are also approved for adminis-

tration to pregnant women during the " flu "

season.

FACTUALLY, givng a Thimerosal-containing

flu shot during pregnancy exposes the fetus

to a significantly higher specific dose

(dose of mercury per kilogram of body mass)

of mercury than an infant receives at 6

months of age.

Hopefully, after reviewing this informa-

tion and confirming its validity on the

appropriate governmental web sites,

http://www.fda.gov for the vaccine

approvals, and

http://www.cdc.gov for the recommendations

for vaccination programs,

you will see that your statement:

>

>Use of thimerasol in routine vaccines

>was stopped in 2001

>

is false.

Finally, UNTIL articles stop misrepre-

senting the facts about the ongoing

presence of Thimerosal in vaccines,

including " routine vaccines " , how can

anyone NOT be concerned about our

current vaccination programs?

Equally important questiona include:

1. " Why do so many feel compelled to lie

about the ongoing presence of Thimerosal

in vaccinces? "

2. " Why does any vaccine still contain

any level Thimerosal -- 9 years after

the promise to remove it from vaccines

in 1999? "

3. " Why have the government's toxicity

studies for Thimerosal, originally

scheduled in 1999, been put on hold

and, most recently transferred to

those responsible for our national

vaccination program? "

IF you want to learn more about the

realities concerning " autism " , THEN,

by all means, you should read the

articles published in the " Documents "

web page on CoMeD's web site:

http://www.mercury-freedrugs.org

and the references cited in those

articles.

Hopefully, if you find the information

presented to be factual, your newspaper

will, at a minimum, print a correction

on the front page of this coming Sunday's

Star Ledger.

Ideally, after studying the evidence, you

may also revise other of your remarks that

seem to be at odds with the fact, like your:

>

>While its prevalence has soared in recent

>years, experts are unsure whether more

>cases are occurring or simply more cases

>are being diagnosed.

>

which ignores the educational reality that

children with a full autism diagnosis were

virtually unknown in our schools and

communities even 30 years ago, or your:

>

>A major study released last year in the

>New England Journal of Medicine shows

>no association between long-term

>neurological and psychological problems

>and early exposure to thimerasol --

>which contains mercury -- in shots.

>

which apparently references:

WW, Price C, Goodson B et al.

Early thimerosal exposure and neuro-

psychological outcomes at 7 to 10 years.

N. Engl. J. Med. 357, 1281-1292 (2007),

a study that:

a. Excluded those with a diagnosis

of an ASD and

b. Still found evidence of a link

between Thimerosal exposure and

" tics " ,

and ignores the 2007 and 2008 papers that

have clearly reaffirmed the factual reality

of the vaccines/Thimerosal link to neuro-

developmental disorders, inclusing autism,

in multiple epidemiologic, animal model,

and post-mortem autopsy studies of the

brains of those with an ASD diagnosis as

well as in a medical decision by the DHHS

in Hannah Poling v. Secretary of HHS, 02-

01466V in the US Court of Federal Claims

in November of 2007, and the April 2007

(PowerPoint Presentation) by Dr. Larry

Needham, Chief, Organic Analytical Toxicology

Branch, Nat'l Center for Environmental Health,

CDC, " Exposure (To Stressors) and Autism

Spectrum Disorders " to the National Academy

of Science's Institute of Medicine (IOM).

Perhaps, after studying the facts, your

next article will be more factually

accurate.

*******************************************

*The information provided in this email *

*and any attachment thereto is just that *

* -- information. *

* *

*It is not medical advice and it does not *

*require any specific action or actions. *

* *

*While the information is thought to be *

*accurate, no representation is made as *

*to the accuracy of the information posted*

*other than it is my best understanding of*

*the facts on the date that this email and*

*any attachments thereto are posted. *

* *

*Everyone should verify the accuracy of *

*the information provided for themselves *

*before acting on it. *

*******************************************

Respectfully,

Dr. King

http://www.dr-king.com

+++++++++++++++++++++++++++++++++++++